Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11420)
All Articles published online
|
Publishing Process of This Article
|
May 21, 2014 (publication date) through May 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kumar N, Kedarisetty CK, Kumar S, Khillan V, Sarin SK. Antitubercular therapy in patients with cirrhosis: Challenges and options. World J Gastroenterol 2014; 20(19): 5760-5772 [PMID: 24914337 DOI: 10.3748/wjg.v20.i19.5760] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i19/5760.htm |
| Number | Citing Articles |
| 1 |
Yun Zhang, Kechun Liu, Hozeifa M. Hassan, Hongli Guo, Pingping Ding, Liwen Han, Qiuxia He, Weiyun Chen, Chung-Der Hsiao, Luyong Zhang, Zhenzhou Jiang. Liver Fatty Acid Binding Protein Deficiency Provokes Oxidative Stress, Inflammation, and Apoptosis-Mediated Hepatotoxicity Induced by Pyrazinamide in Zebrafish Larvae. Antimicrobial Agents and Chemotherapy 2016; 60(12): 7347 doi: 10.1128/AAC.01693-16
|
| 2 |
Tsung-Hsing Hung, Chorng-Jang Lay, Chih-Wei Tseng, Chih-Chun Tsai, Chen-Chi Tsai. The Effect of Tuberculosis on the Mortality of Cirrhotic Patients. Medicine 2014; 93(28): e295 doi: 10.1097/MD.0000000000000295
|
| 3 |
Saurabh Mishra, Sunil Taneja, Arka De, Valliappan Muthu, Nipun Verma, Madhumita Premkumar, Ajay Duseja, Virendra Singh. Tuberculosis in Cirrhosis – A Diagnostic and Management Conundrum. Journal of Clinical and Experimental Hepatology 2022; 12(2): 278 doi: 10.1016/j.jceh.2021.09.003
|
| 4 |
Niyati Narsana, María Alejandra Pérez, Aruna Subramanian. Mycobacteria in Organ Transplant Recipients. Infectious Disease Clinics of North America 2023; 37(3): 577 doi: 10.1016/j.idc.2023.04.004
|
| 5 |
Swati Sharma, Vishal Sharma, Sunil Taneja, Alka Bhatia, Aishwarya Anand, Dibyajyoti Banerjee, Amol N. Patil. Pharmacokinetic Assessment of Pyrazinamide and Pyrazinoic Acid in Carbon tetrachloride-induced Liver Injury Model in Wistar Rats. Journal of Pharmacy and Bioallied Sciences 2023; 15(3): 146 doi: 10.4103/jpbs.jpbs_333_23
|
| 6 |
Rahul Pal, Saif Hameed, Parveen Kumar, Sarman Singh, Zeeshan Fatima. Comparative lipidomics of drug sensitive and resistant Mycobacterium tuberculosis reveals altered lipid imprints. 3 Biotech 2017; 7(5) doi: 10.1007/s13205-017-0972-6
|
| 7 |
Ahmed Aliyu Abulfathi, Eric H. Decloedt, Elin M. Svensson, Andreas H. Diacon, Peter Donald, Helmuth Reuter. Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis. Clinical Pharmacokinetics 2019; 58(9): 1103 doi: 10.1007/s40262-019-00764-2
|
| 8 |
Gabriel A. Gutiérrez-Rebolledo, A. Georgina Siordia-Reyes, Mariana Meckes-Fischer, Adelina Jiménez-Arellanes. Hepatoprotective properties of oleanolic and ursolic acids in antitubercular drug-induced liver damage. Asian Pacific Journal of Tropical Medicine 2016; 9(7): 644 doi: 10.1016/j.apjtm.2016.05.015
|
| 9 |
Sanjeev Gautam, Keshav Raj Sigdel, Sudeep Adhikari, Buddha Basnyat, Buddhi Paudyal, Jiwan Poudel, Ujjwol Risal. Case Report: Pulmonary tuberculosis and raised transaminases without pre-existing liver disease- Do we need to modify the antitubercular therapy?. Wellcome Open Research 2020; 5: 193 doi: 10.12688/wellcomeopenres.16175.2
|
| 10 |
Seiyed Mohammad Ali Ghayumi, Alireza Shamsaeefar, Nasrin Motazedian, Amirali Mashhadiagha, Mehrab Sayadi, Saman Nikeghbalian, Seyed Ali Malekhosseini. Isoniazid prophylaxis in liver transplant recipient with latent tuberculosis: Is it harmful for transplanted liver?. Transplant Infectious Disease 2022; 24(4) doi: 10.1111/tid.13849
|
| 11 |
Marcela Munoz-Torrico, Norma Téllez-Navarrete, Heinke Kunst, Nguyen Nhat Linh. Essential Tuberculosis. 2021; : 131 doi: 10.1007/978-3-030-66703-0_14
|
| 12 |
Ajay S. Shinde, Dharmesh Kapoor. Infections After Liver Transplant -Timeline, Management and Prevention. Journal of Clinical and Experimental Hepatology 2024; 14(3): 101316 doi: 10.1016/j.jceh.2023.101316
|
| 13 |
Petros G Mantzios, Panagiota Spyropoulou, Sophia Hatzianastasiou, Dimitrios Efthymiou , Efthymios Filippopoulos, Christos Mamarelis, Charalampos Potsios, Konstantina Filioti, Constantinos A Letsas. Pediococcus pentosaceus Endocarditis in a Patient With Recent Transcatheter Aortic Valve Implantation and Liver Cirrhosis: A Case Report and Review of the Literature. Cureus 2024; doi: 10.7759/cureus.57509
|
| 14 |
Payam Nahid, Susan E. Dorman, Narges Alipanah, Pennan M. Barry, Jan L. Brozek, Adithya Cattamanchi, Lelia H. Chaisson, Richard E. Chaisson, Charles L. Daley, Malgosia Grzemska, Julie M. Higashi, Christine S. Ho, Philip C. Hopewell, Salmaan A. Keshavjee, Christian Lienhardt, Richard Menzies, Cynthia Merrifield, Masahiro Narita, Rick O'Brien, Charles A. Peloquin, Ann Raftery, Jussi Saukkonen, H. Simon Schaaf, Giovanni Sotgiu, Jeffrey R. Starke, Giovanni Battista Migliori, Andrew Vernon. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clinical Infectious Diseases 2016; 63(7): e147 doi: 10.1093/cid/ciw376
|
| 15 |
Y.-P. Lim, C.-L. Lin, D.-Z. Hung, Y.-N. Lin, C.-H. Kao. Anti-tuberculosis treatments and risk of hepatocellular carcinoma in tuberculosis patients with liver cirrhosis: a population-based case–control study. European Journal of Clinical Microbiology & Infectious Diseases 2015; 34(3): 479 doi: 10.1007/s10096-014-2251-3
|
| 16 |
Li Xu, Fei Zhang, Chen Xu, Kai-ge Liu, Wei Wu, Ying-xuan Tian. Is the Prophylactic Use of Hepatoprotectants Necessary in Anti-Tuberculosis Treatment?. Chemotherapy 2017; 62(5): 269 doi: 10.1159/000465515
|
| 17 |
Swati Chouhan, Prajna Anirvan, Shivaram Prasad Singh. Pharmacotherapy for Liver Cirrhosis and Its Complications. 2022; : 49 doi: 10.1007/978-981-19-2615-0_4
|
| 18 |
Bernardina Scafuri, Anna Marabotti, Virginia Carbone, Paola Minasi, Serena Dotolo, Angelo Facchiano. A theoretical study on predicted protein targets of apple polyphenols and possible mechanisms of chemoprevention in colorectal cancer. Scientific Reports 2016; 6(1) doi: 10.1038/srep32516
|
| 19 |
Maria Adriana Rangel, Isabel Pinto Pais, Raquel Duarte, Isabel Carvalho. Antituberculosis Drug-Induced Liver Injury with Autoimmune Features: Facing Diagnostic and Treatment Challenges. Case Reports in Pediatrics 2017; 2017: 1 doi: 10.1155/2017/5741896
|
| 20 |
Passisd Laoveeravat, Nicha Wongjarupong, Chonlada Phathong, Cameron Hurst, Sombat Treeprasertsuk, Rungsun Rerknimitr, Roongruedee Chaiteerakij. Characteristics and risk factors for antituberculosis drug-induced liver injury in a cohort of patients with cirrhosis in a tertiary referral university teaching hospital in Thailand. Asian Biomedicine 2019; 12(2): 65 doi: 10.1515/abm-2019-0003
|
| 21 |
Jose Tiago Silva, Rafael San-Juan, Mario Fernández-Ruiz, José María Aguado. Fluoroquinolones for the treatment of latent <i>Mycobacterium tuberculosis</i> infection in liver transplantation. World Journal of Gastroenterology 2019; 25(26): 3291-3298 doi: 10.3748/wjg.v25.i26.3291
|
| 22 |
Cecile Magis-Escurra, Anna Cristina C. Carvalho, Afrânio L. Kritski, Enrico Girardi. Tuberculosis. 2018; : 276 doi: 10.1183/2312508X.10022017
|
| 23 |
RuiLing Wang, Peng Zhu. Letter to the Editor: Tuberculosis and Antituberculosis Treatments Cannot Be Ignored When Evaluating Patients With Cirrhosis Who Are Coinfected With HIV or Not. Hepatology 2019; 70(1): 448 doi: 10.1002/hep.30582
|